Michael Glenn Miles serves as Executive at CANCER GENETICS, INC, where they oversee executive responsibilities. Since joining the company, Michael Glenn Miles has executed 1 insider transactions totaling $34.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 31, 2019 involved purchasing 150,000 shares valued at $34.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 31, 2019 | CGIX | $34.5K | Purchase | 150,000 | $0.23 | Discretionary |
Michael Glenn Miles currently holds 150,000 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Glenn Miles has been a net buyer of CGIX stock. They have purchased $34.5K and sold $0 worth of shares.
Michael Glenn Miles's most recent insider trade was on Jan 31, 2019, when they purchased 150,000 shares at $0.23 per share.
Get notified when new Form 4 filings are submitted